STANDARD BIOTOOLS INC. - 10-Q Filing
Standard BioTools Inc. reports Q3 2026 financial results including restructuring charges and updates on SomaScan business segment.
Tickers: $LAB
Standard BioTools Inc. reports Q3 2026 financial results including restructuring charges and updates on SomaScan business segment.
Tickers: $LAB